Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) Study
- 15 March 1998
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 89 (6), 281-287
- https://doi.org/10.1016/s0049-3848(98)00018-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placeboThe Lancet, 1996
- Major orthopaedic surgery and post-discharge DVTThe Lancet, 1996
- Haemostatic Activation before and after Surgery in Patients with and without Gastric MalignancyThrombosis and Haemostasis, 1994
- Postoperative Pulmonary Embolism After Hospital DischargeArchives of Surgery, 1992
- Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyThrombosis Research, 1991
- Comparison of Real-Time B-Mode Ultrasonog raphy and Bilateral Ascending Phlebography for Detection of Postoperative Deep Vein Thrombosis Following Elective Hip SurgeryThrombosis and Haemostasis, 1989
- Deep venous thrombosis: a continuing problem.BMJ, 1988
- Phlebographic Signs in Fresh Postoperative Venous Thrombosis of the Lower ExtremityActa Radiologica. Diagnosis, 1973
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972
- PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS: A Trial of Anticoagulant Prophylaxis with Phenindione in Middle-aged and Elderly Patients with Fractured Necks of FemurThe Lancet, 1959